KEN SHE Study on HPV-vaccine Efficacy

Project Participants

Enrollment for the KEN SHE Study is now completed, with 2275 people enrolled in the study for 3 years (2019-2022). For more information about what the study will entail, please visit the Study Design page or view our Project Brochures.


Benefits of joining the KEN SHE Study

Free HPV vaccination to prevent cervical cancer

Free cervical cancer screening

Free STI screening and treatment

Free meningococcal vaccination to prevent meningitis

Free HIV & pregnancy testing and counseling

Free reproductive health services


For more information about enrollment, contact Hannah Leingang, the Study Coordinator, or your local site coordinator: Contact Information